208 related articles for article (PubMed ID: 21835799)
1. Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.
Morrison MA; Morreale RJ; Akunuru S; Kofron M; Zheng Y; Wells SI
J Virol; 2011 Oct; 85(20):10487-98. PubMed ID: 21835799
[TBL] [Abstract][Full Text] [Related]
2. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
3. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
4. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
5. Transition to an irreversible state of senescence in HeLa cells arrested by repression of HPV E6 and E7 genes.
Kang HT; Lee CJ; Seo EJ; Bahn YJ; Kim HJ; Hwang ES
Mech Ageing Dev; 2004 Jan; 125(1):31-40. PubMed ID: 14706235
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
[TBL] [Abstract][Full Text] [Related]
7. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
8. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
9. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cellular proliferation by the papillomavirus E2 protein.
Dowhanick JJ; McBride AA; Howley PM
J Virol; 1995 Dec; 69(12):7791-9. PubMed ID: 7494290
[TBL] [Abstract][Full Text] [Related]
11. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
12. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.
Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637
[TBL] [Abstract][Full Text] [Related]
13. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
Lee CJ; Suh EJ; Kang HT; Im JS; Um SJ; Park JS; Hwang ES
Exp Cell Res; 2002 Jul; 277(2):173-82. PubMed ID: 12083799
[TBL] [Abstract][Full Text] [Related]
14. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
[TBL] [Abstract][Full Text] [Related]
17. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
[TBL] [Abstract][Full Text] [Related]
18. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.
Magaldi TG; Almstead LL; Bellone S; Prevatt EG; Santin AD; DiMaio D
Virology; 2012 Jan; 422(1):114-24. PubMed ID: 22056390
[TBL] [Abstract][Full Text] [Related]
19. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
20. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
